Cancers treated with Robotic Surgery include Bladder Cancer, Cervical Cancer, Head & Neck Cancer, Kidney Cancer, Lung Cancer, Ovarian Cancer, Prostate Cancer and Uterine Cancer.
KIMS surgeons are using cutting-edge technology to perform robotic partial nephrectomy for kidney cancer, a delicate procedure used to treat kidney cancer. Fine articulating instruments, under the command of the surgeon, are used to precisely remove the tumor alone and preserve the remaining kidney. The surgery can be performed using very small incisions, greatly decreasing recovery time, reducing pain and minimizing scarring. This allows for patients to return to their daily lives with a minimum of inconvenience, despite having undergone major surgery. Kidney specialists are gaining greater understanding of the benefits of partial nephrectomy. Not only does it decrease the risk of future kidney failure, but can also improve health in other ways, such as in preventing future cardiovascular disease. Although the surgery is technically more challenging, KIMS surgeons have extensive experience in performing robotic partial nephrectomy, with a low overall complication rate.
Robotic prostate surgery, uses finely controlled robotic instruments to perform the surgery safely while enhancing patient recovery and outcome for prostate cancer. Sitting at the da Vinci surgical console, surgeons perform robotic prostate surgery by controlling the device consisting of high-resolution cameras and micro-surgical instruments. Powered by state-of-the-art robotic technology, the surgeon's hand movements are scaled, filtered and seamlessly translated into precise movement of the EndoWrist Instruments. Unlike laparoscopic surgery, da Vinci Surgical System instruments used in robotic prostate surgery can turn in all directions with 90 degrees of articulation and 7 degrees of freedom. During robotic prostate surgery the da Vinci robot provides the surgeon with improved visualization, dexterity, and precision compared with open or laparoscopic surgery, while enabling operation through 1-2 cm incisions. This allows surgeons to perform fine computer-controlled movements and to perform a more precise and minimally invasive robotic prostate surgery, protecting his patients' delicate prostate nerves that control bladder and sexual function. Robotic prostate surgery achieves the same or better results than using a surgeon's own hands in open or laparoscopic surgery.
Robotic cystectomy is simply a newer, more effective, minimally invasive surgical method for bladder cancer. This procedure utilizes the da Vinci Surgical System in which a robotic arm imitates the surgeon's movements, amplifying their precision. It offers bladder cancer patients the prospect of a more effective surgery and less problematic post-surgical recovery. It is fast becoming the preferred answer for bladder cancer surgery. This surgical procedure allows the surgeon to make smaller incisions which spare vital, but delicate, nerve and muscle tissue. The patient experiences a shorter hospital stay, fewer complications, and a faster recovery time. Similar to a standard laparoscopic cystectomy, the robotic-assisted cystectomy may require a urinary diversion with subsequent reconstruction for the removed bladder. For men and women alike, such reconstruction would include a continence reservoir which holds urine in the abdominal cavity until the patient has been fitted with a catheter to empty urine or a bladder replacement and an external bag for urine collection. The da Vinci Surgical System provides the physician with a superior visualization plane and improved surgical dexterity during bladder removal and, if necessary, a reconstructive procedure.
Standard surgical approaches, chemotherapy, and radiation therapy are only moderately successful in treating oral cancer, and traditional surgery can involve splitting the jawbone open to fully access and remove malignancies. Transoral robotic surgery offers improved cure rates and fewer complications. During the procedure, an assistant is positioned at the patient's head to provide suction or traction or other support. The surgeon manipulates controls inside a workstation console several feet from the operating table while looking through binoculars equipped with a high-resolution 3-D stereoscopic imaging system. The surgical instruments are equipped with articulating tips and wrist mobility that improve precision. This sensitivity enhances a surgeon's ability to navigate challenging anatomy, to deftly perform microresection, and to precisely place sutures.
In robotic lung cancer surgery, the surgeons operate through small incisions in the chest to remove the tumor and a certain amount of surrounding healthy tissue from the affected lobe. (The right lung is made up three lobes, while the left lung is made up of two.) Our robotic thoracic surgeonsperform several different types of lung cancer procedures, depending on the size and location of the tumor. In a robotic wedge resection, the surgeon removes a small, wedge-shaped portion of lung, including the tumor and a certain amount of healthy tissue around it. In a robotic sub-lobar resection, the surgeon removes a portion of the anatomic segment that has the tumor in it, as well as some normal surrounding lung. In a robotic lobectomy, the surgeon removes the entire affected lobe. In all three of these procedures, a robotic lymph node dissection (surgical removal of the nearby lymph nodes around the lung and mediastinum) is also performed in order to evaluate whether the cancer has progressed beyond the lungs.
The robot-assisted standard treatment, utilized by most patients who choose to undergo surgical treatment for their cervical cancer, is robotic radical hysterectomy, involving removal of the uterus, cervix, upper vagina and bilateral parametria (bands of connective tissue in the pelvis). This procedure also includes a robotic pelvic lymphadenectomy (removal of the pelvic lymph nodes), which is done for cancer control and to help determine the extent of the cancer.
For cervical cancer patients wishing to preserve fertility, a robotic radical trachelectomy is the preferred approach. In this procedure, the cervix, upper vagina and bilateral parametria are removed, but the uterus is left untouched. Since the success of this procedure depends on the characteristics of the cancer being treated, a radical trachelectomy is perfomed only in carefully selected patients after extensive discussion with their gynecologic oncologist.
In robot-assisted surgical treatment of endometrial cancer, the standard procedure is to perform a robotic simple hysterectomy (involving removal of the uterus and cervix), along with robotic bilateral salpingo-oophorectomy (removal of both ovaries and fallopian tubes) and a series of staging procedures, in which tissues are sampled to gauge the extent of the cancer—a key step that is used to guide post-operative chemotherapy and other future treatments Because the da Vinci system requires only a few tiny incisions and offers greater vision, precision and control for the surgeon, patients can often recover sooner, move on to additional treatments if needed and get back to life quicker.